Mid Atlantic Financial Management’s iShares Biotechnology ETF IBB Stock Holding History

Mid Atlantic Financial Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$865K	Buy	5,353 +57	+1%	+$9.59K	0.06%	293
2021 Q2	$867K	Buy	5,296 +8	+0.2%	+$1.23K	0.06%	288
2021 Q1	$796K	Sell	5,288 -20,428	-79%	-$3.24M	0.06%	305
2020 Q4	$3.9M	Sell	25,716 -23,217	-47%	-$3.32M	0.3%	81
2020 Q3	$6.74M	Sell	48,933 -7,454	-13%	-$1.01M	0.59%	28
2020 Q2	$7.71M	Buy	56,387 +53,249	+1,697%	+$6.79M	0.74%	26
2020 Q1	$338K	Buy	3,138 +158	+5%	+$18.2K	0.04%	407
2019 Q4	$359K	Sell	2,980 -20	-0.7%	-$2.23K	0.03%	479
2019 Q3	$299K	Sell	3,000 -545	-15%	-$57K	0.03%	509
2019 Q2	$387K	Sell	3,545 -1,134	-24%	-$121K	0.04%	440
2019 Q1	$523K	Buy	4,679 +832	+22%	+$91.3K	0.06%	351
2018 Q4	$371K	Buy	+3,847	New	+$408K	0.05%	420

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Mid Atlantic Financial Management's IBB Position: Q3 2021 in Review

Mid Atlantic Financial Management increased its iShares Biotechnology ETF (IBB) stake by 1.1% in Q3 2021, buying an estimated $9.59K and bringing the position to 5,353 shares worth $865K. The position accounts for 0.06% of the portfolio, ranked #293.

Mid Atlantic Financial Management first reported a position in IBB in Q4 2018 and has held it in 12 quarters since. The position peaked at $7.71M in Q2 2020. 855 funds tracked by Wall St. Rank hold IBB as of Q3 2021.

Mid Atlantic Financial Management held 5,353 shares of iShares Biotechnology ETF worth $865K as of Q3 2021.
Mid Atlantic Financial Management bought 57 iShares Biotechnology ETF shares in Q3 2021, an estimated $9.59K.
iShares Biotechnology ETF made up 0.06% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #293 holding.
Mid Atlantic Financial Management first reported a position in iShares Biotechnology ETF in Q4 2018 and has held it in 12 quarters since.
Mid Atlantic Financial Management's iShares Biotechnology ETF position peaked at $7.71M in Q2 2020.
855 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.